Evidence map

ArticleExpert opinion on drug discovery2026

The impact of antisense oligonucleotide (ASO) therapeutics on the future of rare disease drug discovery.

Ruchi Ruchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41887927